# Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)

> **NCT06177574** · PHASE4 · COMPLETED · sponsor: **Carmen Hidalgo Tenorio** · enrollment: 208 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** BIC/FTC/TAF

## Key facts

- **NCT ID:** NCT06177574
- **Lead sponsor:** Carmen Hidalgo Tenorio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-27
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2023-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177574, "Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06177574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*